retatrutide trial results Results: 28.3% Weight Loss Data 🚨The first phase 3 retatrutide

IGF-1 is what actually drives the shift in body composition

Intestinal bacteria: Thyroid disease and intestinal disease commonly coexist, probably because of disruption of the intestinal barrier, where it is easier for antigens to pass through and react with the immune system or with extra-intestinal tissues to intersect and destroy thyroid cells

While B12 is crucial, other essential nutrients contribute to power and focus

Edwin Lee reported outcomes in a limited cohort of 16 patients presenting with knee pain, where 14 of 16 individuals (87.5%) experienced symptomatic improvement following treatment with BPC-157